NICOTINAMIDE MAY EXTEND REMISSION PHASE ININSULIN-DEPENDENT DIABETES
- 14 March 1987
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 329 (8533) , 619-620
- https://doi.org/10.1016/s0140-6736(87)90250-9
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- CYCLOSPORIN INCREASES THE RATE AND LENGTH OF REMISSIONS IN INSULIN-DEPENDENT DIABETES OF RECENT ONSETThe Lancet, 1986
- Sustained initial remission induced by intensive insulin treatment in type I diabetes. Possible role of the genetic BackgroundActa Diabetologica, 1985
- Amelioration of Diabetes Mellitus in Partially Depancreatized Rats by Poly(ADP-ribose) Synthetase Inhibitors: Evidence of Islet B-Cell RegenerationDiabetes, 1984
- Preventive and Therapeutic Effects of Large-Dose Nicotinamide Injections on Diabetes Associated with Insulitis: An Observation in Nonobese Diabetic (NOD) MiceDiabetes, 1982
- Studies of streptozotocin-induced insulitis and diabetes.Proceedings of the National Academy of Sciences, 1977
- Streptozotocin Diabetes: Time Course of Irreversible B-Cell Damage; Further Observations on Prevention by NicotinamideExperimental Biology and Medicine, 1970